Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 6/20 | 0.50 |
| ▸ | CTSK | P43235 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3323682 | 1.00 | CTSS (0.50) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL1486220 | 1.00 | CTSS (0.50) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL30797870 | 0.93 | CTSS (0.49) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL6735984 | 0.93 | CTSS (0.46) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL30797986 | 0.93 | CTSS (0.49) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL20267196 | 0.88 | CTSS (0.47) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL20267198 | 0.88 | CTSS (0.47) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL1235161 | 0.87 | CTSK (0.49) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL12486933 | 0.87 | CTSK (0.49) | CTSSCTSKPPARAPPARGCTSL | |
| SCHEMBL343678 | 0.87 | CYP2D6 (0.55) | CTSSCTSKPPARAPPARGCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| US-20250230356-A1 | THINNER COMPOSITION | DONGWOO FINE-CHEM CO., LTD. (KR) | 2025-07-17 | — | — | US | claimed |
| CN-120192431-A | Self-assembled polypeptide probe for enhancing tumor magnetic resonance imaging | 东南大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119708129-A | Polypeptide fluorescent probe capable of specifically detecting enterokinase and preparation method and application thereof | 南京工业大学 | 2025-03-28 | — | — | CN | claimed |
| CN-118852337-A | Antitumor drug and preparation method thereof | 广西中医药大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118684732-A | Method for preparing AT-01 by liquid phase fragment condensation | 南通大学 | 2024-09-24 | — | — | CN | claimed |
| CN-118666947-A | Polypeptide modified taxol 2' -hydroxycarbonylpentanoyl derivative and its synthesis, activity and application | 首都医科大学 | 2024-09-20 | — | — | CN | claimed |
| CN-118580305-A | Dimer of ursolic acid-Asp-Gly-Glu-Ala and synthesis and application thereof | 首都医科大学 | 2024-09-03 | — | — | CN | claimed |
| CN-115403654-B | Ursolic acyl-Asp-Gly-Glu-Ala, synthesis, activity and application thereof | 首都医科大学 | 2024-06-18 | — | — | CN | claimed |
| CN-117512596-A | Tin-copper-titanium etching solution | 湖北兴福电子材料股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-102796171-A | Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-11-28 | — | — | CN | claimed |
| CN-102796169-A | Double saturated aliphatic chain alcohol Glu-Asp-Gly-Asp tetrapeptide esters and preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-11-28 | — | — | CN | claimed |
| CN-100590068-C | Method for preparing primary amine carbon nano tube | UNIV TONGJI | 2010-02-17 | — | — | CN | claimed |
| CN-101177259-A | Method for preparing primary amine carbon nano tube | UNIV TONGJI (CN) | 2008-05-14 | — | — | CN | claimed |
| CN-1241935-C | Liquid phase sgnthesis method of thymus pentapeptide | UNIV LANZHOU (CN) | 2006-02-15 | — | — | CN | claimed |
| CN-1202131-C | Technology of one kettle method for liquid phase synthesizing thymopentapeptide | UNIV JILIN (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1513872-A | Liquid phase sgnthesis method of thymus pentapeptide | 兰州大学 | 2004-07-21 | — | — | CN | claimed |
| CN-1442428-A | Technology of one kettle method for liquid phase synthesizing thymopentapeptide | UNIV JILIN (CN) | 2003-09-17 | — | — | CN | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| US-6395077-B1 | INKS WITH BENZOYLBENZOIC ACID AND COLORS | XEROX CORPORATION | 2002-05-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | CTSS 1745/4885CTSK 1879/4885PPARA 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.